. 2020 Nov 4;2020(11):CD013218. doi: 10.1002/14651858.CD013218.pub2

3. Direct comparisons between OnSite Pf/Pv test and Falcivax Device Rapid test.

Study	Reference standard	Sensitivity (true positives/malaria cases) (%)		Difference (95% CI) (percentage points)	P value	Specificity (true negatives/non‐cases) (%)		Difference (95% CI) (percentage points)	P value
Study	Reference standard	OnSite Pf/Pv test (CTK Biotech Inc, USA)	Falcivax Device Rapid test for malaria Pv/Pf (Zephyer Biomedicals, Goa)	Difference (95% CI) (percentage points)	P value	OnSite Pf/Pv test (CTK Biotech Inc, USA)	Falcivax Device Rapid test for malaria Pv/Pf (Zephyer Biomedicals, Goa)	Difference (95% CI) (percentage points)	P value
Alam 2011	Microscopy	90 (19/21)	90 (19/21)	0 (‐17.8 to 17.8)	P = 1.00	99 (313/317)	100 (316/317)	0.9 (‐0.4 to 2.3)	P = 0.18
Alam 2011	PCR	77 (20/26)	77 (20/26)	0 (‐22.9 to 22.9)	P = 1.00	99 (309/312)	100 (312/312)	1.0 (‐0.1 to 2.0)	P = 0.08

PCR = polymerase chain reaction.